7Vote!
Market Wire (Free subscription) | 11/24/2009
GREENWICH, CT (MARKET WIRE) On October 5th, 2009, the Stone Point Capital Foundation hosted its fifth Charity Golf Tournament and Dinner at The Stanwich Club of Greenwich, to benefit The Fibrolamellar Cancer Foundation. The event drew more than 140 golfers and 200 dinner attendees to hear speakers Dr. Ronald DeMatteo and Dr. David Sidransky discuss fibrolamellar cancer, a rare form of liver cancer...
4Vote!
Health's Gold (Free subscription) | yesterday
You drank alcohol? If yes, prepared to start changing drinking habits were. Because is routine alcohol believed to consume can trigger the growth of seven types of alcohol on a regular basis cancer. Drink was not only interfering with heart health, but also trigger the growth and development of seven types of recent studies cancer. Result McGill University in Montreal, Canada, found that heavy drinkers...
3Vote!
Labourlist (Free subscription) | 11/24/2009
The Amanjit Jhund NHS column The news this week in the world of healthcare has been dominated by another instance of the National Institute of Clinical Excellence (NICE) refusing to authorise the use of a potentially life-prolonging drug in cancer care. I personally have no problem with the decision on medical grounds; I recognise that the NHS does not unfortunately have unlimited funds at its disposal...
7Vote!
P/Oed Patriot (Free subscription) | 11/23/2009
I f anyone has a Doubt that a Public Health Care System leads to Government Rationing Health Care all anyone has to do is look to England for Proof. According to an Article on the Telegraph.UK, the National Health Service(NHS) has declared a Troubled Marriage an "illness" which will require the Government to pay for Marriage Counseling. But what has outraged so many Britons is that while...
4Vote!
Medical News Today (Free subscription) | 11/23/2009
In patients with unresectable (unable to be removed by surgery) liver cancer, an interventional radiology procedure called triple-drug transcatheter arterial chemoemobolization (TACE) followed by a liver transplant may significantly increase a patient's chance of long-term survival, according to a study published in the December issue of the American Journal of Roentgenology.
3Vote!
The Guardian (Free subscription) | 11/23/2009
The chairman of the Parole Board rightly states that the justice secretary should play no part in deciding whether terminally ill prisoners should be released on compassionate grounds ( Report , 18 November). Politicians are not involved in individual sentencing decisions and there should be no suggestion that political considerations might have influenced the release date of someone serving an indeterminate...
6Vote!
The Right Coast (Free subscription) | 11/21/2009
Dr Harpreet Wasan, a cancer consultant at London's Hammersmith Hospital, said: 'This cancer is not like any other cancer. There is no alternative treatment. Every other drug that has been tried fails to work. via www.dailymail.co.uk
3Vote!
The Guardian (Free subscription) | 11/21/2009
Another nasty decision for Nice this week, as the health service's rationing agency turned down Nexavar , which treats liver cancer. Everyone agrees it provides extra months, but it will not be administered – except to the rich – as it fails to provide enough extra months for the money. The watertight logic is that cash blown on one costly treatment cannot be spent on saving other lives....
4Vote!
Medical News Today (Free subscription) | 11/20/2009
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International conference being held November 15 - 19, 2009 in Boston, Mass.
6Vote!
Eurekalert (Free subscription) | 11/20/2009
In patients with unresectable (unable to be removed by surgery) liver cancer, an interventional radiology procedure called triple-drug transcatheter arterial chemoemobolization followed by a liver transplant may significantly increase a patient's chance of long-term survival, according to a study published in the December issue of the American Journal of Roentgenology.
3Vote!
National Death Service (Free subscription) | 11/19/2009
A drug that can prolong the lives of patients with advanced liver cancer has been rejected for use in the NHS in England, Wales and Northern Ireland. The National Institute for Health and Clinical Excellence (NICE) said the cost of Nexavar - about £3,000 a month - was "simply too high". But Macmillan Cancer Support said the decision was "a scandal". More than 3,000 people...
4Vote!
thepharmaletter.com (Free subscription) | 11/19/2009
Following a further appraisal, the UK’s National Institute for Health and Clinical Excellence (NICE) has again decided against recommending the use of German drug major Bayer’s Nexavar (sorafenib) under the National Health Service for advanced hepatocellular carcinoma (HCC) in patient for whom surgery or therapies in the region the cancer arose have failed or are not suitable, essentially...
3Vote!
SOCIALIZED MEDICINE (Free subscription) | 11/19/2009
Condemned to an early death: British rationing body tells liver cancer victims that life-prolonging drug is 'too costly' Liver cancer sufferers are being condemned to an early death by being denied a new drug on the Health Service, campaigners warn. They criticised draft guidance that will effectively ban the drug sorafenib - which is routinely used in every other country where it is licensed. Trials...
5Vote!
Law Blog - WSJ.com (Free subscription) | 11/19/2009
German pharmaceutical and chemical company Bayer said it will appeal a decision by the U.K.'s health-care cost regulator not to recommend the company's Nexavar for liver cancer treatment.
4Vote!
Market Watch (Free subscription) | 11/19/2009
TEL AVIV (MarketWatch) -- UK health-care regulators are declining to pay for an advanced-liver-cancer drug because it's too expensive relative to its benefits, media reports say. The UK Telegraph reported that 600 to 700 patients a year would be eligible for Nexavar; Reuters said the drug would cost the National Health Service almost $4900 a month per patient. The National Institute for Health and...
4Vote!
doctorcoin | 11/10/2009
>> Buy desogen online <<< Desogen contains a combination of female hormones that prevent ovulation (the release of an egg from the ovary). Desogen also causes changes in your cervical mucus and uterine lining, making it difficult for sperm to reach the uterus and harder for a fertilized egg to attach to the uterus. Desogen is used as contraception to prevent pregnancy. Desogen may also be used for...
3Vote!
aarkstore | 10/28/2009
Liver Cancer Therapy Area Pipeline Report contains detailed information on the liver cancer drug pipeline. This report provides insight into the pipeline status of liver cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines,...
5Vote!
julieadam | 09/15/2009
No one likes to hear the word ‘Cancer’, but unfortunately, thousands of people are diagnosed with some form of cancer every month. Liver cancer, pancreatic cancer, breast cancer and colon cancer are among the most common. Cancer prevention information is making some headway with encouraging cancer awareness, but too often the diagnosis comes too late. That’s why annual checkups are so important. When...
Videos